[1]NI X, LI Z,LI X,et al.Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China:a cross-sectional study[J].Lancet,2022,400(10357):1020-1032.
[2]ANDRETTA E,COSTA C,LONGOBARDI C,et al.Potential approaches versus approved or developing chronic myeloid leukemia therapy[J].Front Oncol,2021,11:801779.
[3]RAUF A,ABU-IZNEID T,THIRUVENGADAM M, et al.Garlic(Allium sativum L):its chemistry,nutritional composition,toxicity,and anticancer properties[J].Curr Top Med Chem,2022,22(11):957-972.
[4]HE H,MA Y,HUANG H,et al.A comprehensive understanding about the pharmacological effect of diallyl disulfide other than its anti-carcinogenic activities[J].Eur J Pharmacol,2021,893:173803.
[5]DONG HQ,LIANG SJ,XU YL,et al .Liproxstatin-1 induces cell cycle arrest,apoptosis and caspase-3/GSDME-dependent secondary pyroptosis in K562 cells[J].Int J Oncol,2022,61(4):119-120.
[6]SUANGTAMAI T,TANYONG DI.Diallyl disulfide induces apoptosis and autophagy via mTOR pathway in myeloid leukemic cell line[J].Tumour Biol,2016,37(8):10993-10999.
[7]LIU SW,SONG WJ,MA GK,et al.Pyroptosis and its role in cancer[J].World J Clin Cases,2023,11(11):2386-2395.
[8]WEI X,XIE F,ZHOU X,et al.Role of pyroptosis in inflammation and cancer[J].Cell Mol Immunol,2022,19(9):971-992.
[9]AL MA,MIMI AA,AZIZ MA,et al.Role of pyroptosis in cancer and its therapeutic regulation[J].Eur J Pharmacol,2021,910:174444.
[10]YU P,ZHANG X,LIU N,et al.Pyroptosis:mechanisms and diseases[J].Signal Transduct Target Ther,2021,6(1):128.
[11]VASUDEVAN SO,BEHL B,RATHINAM VA.Pyroptosis-induced inflammation and tissue damage[J].Semin Immunol,2023,69:101781.
[12]LIU X,XIA S,ZHANG Z,et al.Channelling inflammation:gasdermins in physiology and disease[J].Nat Rev Drug Discov,2021,20(5):384-405.
[13]LIU Z,WANG C,LIN C.Pyroptosis as a double-edged sword:The pathogenic and therapeutic roles in inflammatory diseases and cancers[J].Life Sci,2023,318:121498.
[14]LU X,GUO T,ZHANG X.Pyroptosis in cancer:friend or foe[J].Cancers (Basel),2021,13(14):3620-3621.
[15]RAO Z,ZHU Y,YANG P,et al.Pyroptosis in inflammatory diseases and cancer[J].Theranostics,2022,12(9):4310-4329.
[16]MAGNANI L,COLANTUONI M,MORTELLARO A. Gasdermins:new therapeutic targets in host defense,inflammatory diseases,and cancer[J].Front Immunol,2022,13:898298.
[17]DE SCHUTTER ELKE,LIESELOT C,JOE I,et al.GSDME and its role in cancer:from behind the scenes to the front of the stage[J].International Journal of Cancer,2020,148(12):2872-2883.
[18]IBRAHIM J,OP DBK,FRANSEN E,et al.The gasdermin E gene has potential as a pan-cancer biomarker,while discriminating between different tumor types[J].Cancers (Basel),2019,11(11):1810-1811.
[19]LEU WJ, CHANG HS,CHEN IS,et al.Antileukemic natural product induced both apoptotic and pyroptotic programmed cell death and differentiation effect[J].Int J Mol Sci,2021,22(20):11239-11240.
[20]ZHENG Z,BIAN Y,ZHANG Y,et al.Metformin activates AMPK/SIRT1/NF-kappaB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis[J].Cell Cycle,2020,19(10):1089-1104.
[21]CAI J,YI M,TAN Y,et al.Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-IotaIota[J].J Exp Clin Cancer Res,2021,40(1):190.
[22]WANG Y,GAO W,SHI X,et al.Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J].Nature,2017,547(7661):99-103.
[23]REN J,TAO Y,PENG M,et al.Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia[J].Cell Death Dis,2022,13(10):915.